GBT

Global Blood Therapeutics, Inc.

Delisted

GBT was delisted on the 4th of October, 2022.

194 hedge funds and large institutions have $2.18B invested in Global Blood Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 65 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

14% less call options, than puts

Call options by funds: $13.8M | Put options by funds: $16M

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

Holders
194
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.8M
Puts
$16M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$6.04M
52
$6.02M
53
$5.55M
54
$5.49M
55
$5.46M
56
$5.39M
57
$5.29M
58
$5.11M
59
$4.64M
60
$4.03M
61
$3.94M
62
$3.47M
63
$3.42M
64
$3.41M
65
$3.36M
66
$3.31M
67
$3.3M
68
$3.25M
69
$3.25M
70
$2.96M
71
$2.94M
72
$2.89M
73
$2.86M
74
$2.72M
75
$2.66M